| Supplemental Financial Statement Information |
Note 17: Supplemental Financial Statement Information
Other Income (Expense), net
Components of Other Income (Expense), net, are
summarized as follows (in thousands):
| Schedule of other income expense, net |
|
|
|
|
|
|
|
|
| |
|
Year Ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
| Interest Expense (a) |
|
$ |
(656 |
) |
|
$ |
(779 |
) |
| |
|
|
|
|
|
|
|
|
| Gain (Loss) on Revaluation of Warrants (b) |
|
|
(232 |
) |
|
|
63 |
|
| Loss on Revaluation of Equity Investment in YFE (c) |
|
|
(9,830 |
) |
|
|
(1,627 |
) |
| Loss on Partial Disposal of Equity Investment and Share Exchange (d) |
|
|
(1,755 |
) |
|
|
– |
|
| Loss on Transaction (e) |
|
|
– |
|
|
|
(985 |
) |
| Realized Loss on Marketable Securities Investments (f) |
|
|
(37 |
) |
|
|
(611 |
) |
| Gain (Loss) on Foreign Exchange (g) |
|
|
2,313 |
|
|
|
(2,138 |
) |
| Loss on Debt Settlement (h) |
|
|
(1,753 |
) |
|
|
– |
|
| Interest Income (i) |
|
|
76 |
|
|
|
168 |
|
| Finance Lease Interest Expense (j) |
|
|
(22 |
) |
|
|
(87 |
) |
| Gain on Lease Modification (k) |
|
|
4 |
|
|
|
– |
|
| Other (l) |
|
|
(25 |
) |
|
|
2,008 |
|
| Other Expense, net |
|
$ |
(11,261 |
) |
|
$ |
(3,209 |
) |
| |
(a) |
Interest expense during the year ended December 31, 2025 primarily consisted of $0.1 million of interest incurred on the factoring liability and $0.5 million of interest incurred on production facilities. Interest expense during the year ended December 31, 2024 primarily consisted of $0.1 million of interest incurred on the margin loan and $0.7 million of interest incurred on production facilities and bank indebtedness. |
| |
(b) |
The loss on revaluation of warrants during the year ended December 31, 2025 consists of a $0.7 million loss recorded at remeasurement offset by a $0.4 million fair value gain in the period ended March 31, 2025 of the outstanding 7,894,736 Series A warrants and 7,894,736 Series B warrants issued in December 2024. These warrants were classified as a liability in the quarter ended March 31, 2025 and a change in their fair value resulted in a recorded gain due to a decrease of the expiration period. In the quarter ended June 2025, these warrants were reclassified to equity. During the year ended December 31, 2024, the recorded gain on revaluation of warrants was related to the remeasurement of 89,286 outstanding warrants classified as liability, which expired in March 2025. |
| |
(c) |
As the investment in YFE is accounted for under the fair value option, the Company recognized a loss on revaluation of its equity investment in YFE of approximately $9.8 million and $1.6 million for the years ended December 31, 2025 and December 31, 2024, respectively. The loss reflected decreases in YFE’s stock price during the current reporting periods compared to the respective prior reporting periods. The impact of foreign currency translation is excluded and presented separately. |
| |
(d) |
The $1.8 million loss consists of a $1.5 million loss recognized on the disposal of 1,500,000 shares of YFE completed on July 14, 2025, and a $0.3 million loss recognized in connection with the share exchange executed on September 25, 2025. |
| |
(e) |
The Company allocated the total December 2024 offering transaction proceeds among the instruments issued, recognizing the Series A and Series B warrants as a liability at their full fair value. As a result of this allocation, the Company recorded a non-cash loss of $1.0 million. |
| |
(f) |
The realized loss on marketable securities investments of $36,674 recorded in the year ended December 31, 2025, reflects the loss on the sale of marketable securities prior to maturity date. The realized loss on marketable securities investments of $0.6 million recorded in the year ended December 31, 2024, reflected the loss that was not recovered from the investments due to selling securities and issuers’ prepayments of principals on certain mortgage-backed securities. |
| |
(g) |
The gain on foreign exchange during the year ended December 31, 2025 primarily related to the remeasurement of the YFE investment, resulting in a gain of $1.8 million, due to the depreciation of the U.S. dollar against the Euro relative to prior periods. The remaining balance of $0.5 million represents the remeasurement of foreign currency transactions of the Company’s non-U.S. subsidiary that remained outstanding as of the consolidated balance sheet date. The loss on Foreign Exchange during the year ended December 31, 2024 primarily related to the revaluation of the YFE investment, resulting in a loss of $1.0 million due to the Euro depreciating against the U.S. dollar as compared to prior period and a loss of $1.1 million due to the remeasurement of foreign currency transactions of the Company’s non-U.S. subsidiary. |
| |
(h) |
The loss on debt settlement recorded during the year ended December 31, 2025 includes a loss of $0.9 million related to the loan settlement agreement with YFE finalized in April 2025 and a loss of $0.8 million arising from the Section 3(a)(10) transaction completed during the year. |
| |
(i) |
Interest income during the year ended December 31, 2025 primarily consisted of income from investments in marketable securities, net of premium amortization expense, as well as other transactions, including interest income related to an Employee Retention Tax Credit (“ERTC”) receivable and interest income related to the shareholder loan (see Note 20 of the Notes to Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K). Each of these sources was individually immaterial. Interest income during the year ended December 31, 2024 primarily consisted of interest income of $0.1 million, net of premium amortization expense, recorded for the investments in marketable securities, and $0.1 million related to the shareholder loan. |
| |
(j) |
The finance lease interest expense represents the interest portion of the finance lease obligations for equipment purchased under an equipment lease line. |
| |
(k) |
On April 1, 2025, Beacon executed a rent reassignment agreement relinquishing one floor of its office space in Toronto to a new tenant who assumed the lease obligation for that floor. This transaction resulted in a gain of $4,253 on lease modification recorded during the year ended December 31, 2025. |
| |
(l) |
During the year ended December 31, 2025, a net loss of $0.1 million was recognized in connection with the reversal of previously accrued other income related to ERTC claims. Other income had initially been recorded based on anticipated recoveries from submitted claims. Recent legislative developments reduced the expected recoverable amounts, resulting in a partial reversal of the accrued other income. The amount also included approximately $0.1 million of other income, primarily consisting of late fees from select clients on payment plans and credit card rewards. The difference between these amounts is reflected in the net balance presented in thousands. During the year ended December 31, 2024, we recorded $1.2 million in other income related to the ERTC receivable, $0.6 million late fees contract interest income, $0.1 million domain sale income, and $0.1 million income related to credit card rewards and other rebates. |
|